Forcing Divestitures, FTC Gives Nod To Mylan Deal
The U.S. Federal Trade Commission has given the green light to pharmaceutical company Mylan Laboratories' $6.6 billion acquisition of generic-drug maker E. Merck OHG, but the commission forced the companies to...To view the full article, register now.
Already a subscriber? Click here to view full article